0
Original Research |

Use of New Treatment Modalities for Non-small Cell Lung Cancer Care in the Medicare PopulationLung Cancer Treatment Modalities

Michael T. Vest, DO, FCCP; Jeph Herrin, PhD; Pamela R. Soulos, MPH; Roy H. Decker, PhD, MD; Lynn Tanoue, MD, FCCP; Gaetane Michaud; Anthony W. Kim; Frank Detterbeck; Daniel Morgensztern; Cary P. Gross
Author and Funding Information

From the Department of Internal Medicine (Drs Vest, Tanoue, and Michaud), Section of Pulmonary and Critical Care Medicine; Department of Internal Medicine (Dr Herrin), Section of Cardiology; Department of Internal Medicine (Ms Soulos and Dr Gross), Section of General Internal Medicine; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center (Drs Herrin, Decker, Kim, and Gross and Ms Soulos); Department of Therapeutic Radiology (Dr Decker); Department of Surgery (Drs Kim and Detterbeck), Section of Thoracic Surgery; Department of Internal Medicine (Dr Morgensztern), Section of Medical Oncology; and Yale Cancer Center (Dr Morgensztern), Yale School of Medicine, New Haven, CT; and Health Research and Educational Trust (Dr Herrin), Chicago, IL.

Correspondence to: Cary P. Gross, MD, Yale School of Medicine, 333 Cedar St, PO Box 208093, New Haven, CT 06520-8057; e-mail: cary.gross@yale.edu


Funding/Support: This work was supported by a grant from the National Cancer Institute [R01CA149045].

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.


Chest. 2013; 143(2):429-435. doi:10.1378/chest.12-1149
Text Size: A A A
Published online

Background:  Many older patients with early stage non-small cell lung cancer (NSCLC) do not receive curative therapy. New surgical techniques and radiation therapy modalities, such as video-assisted thoracoscopic surgery (VATS), potentially allow more patients to receive treatment. The adoption of these techniques and their impact on access to cancer care among Medicare beneficiaries with stage I NSCLC are unknown.

Methods:  We used the Surveillance, Epidemiology and End Results-Medicare database to identify patients with stage I NSCLC diagnosed between 1998 and 2007. We assessed temporal trends and created hierarchical generalized linear models of the relationship between patient, clinical, and regional factors and type of treatment.

Results:  The sample comprised 13,458 patients with a mean age of 75.7 years. The proportion of patients not receiving any local treatment increased from 14.6% in 1998 to 18.3% in 2007. The overall use of surgical resection declined from 75.2% to 67.3% (P < .001), although the proportion of patients undergoing VATS increased from 11.3% to 32.0%. Similarly, although the use of new radiation modalities increased from 0% to 5.2%, the overall use of radiation remained stable. The oldest patients were less likely to receive surgical vs no treatment (OR, 0.12; 95% CI, 0.09-0.16) and more likely to receive radiation vs surgery (OR, 13.61; 95% CI, 9.75-19.0).

Conclusion:  From 1998 to 2007, the overall proportion of older patients with stage I NSCLC receiving curative local therapy decreased, despite the dissemination of newer, less-invasive forms of surgery and radiation.

Figures in this Article

Sign In to Access Full Content

Want to Purchase a Subscription?

New to CHEST? Become an ACCP member to receive a full subscription to both the print and online editions.
Want to access your Institution's subscription?
Sign in to your individual user account while you are actively authenticated on this website via your institution (Learn more about institutional authentication). We will then sustain your personal access to their content/subscription for 90 days, after which you can repeat this process.

Sign In to Access Full Content

Want to Purchase a Subscription?

New to CHEST? Become an ACCP member to receive a full subscription to both the print and online editions.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
CHEST Collections
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543